8-K current report · filed Nov 9, 2026

DELCATH SYSTEMS, INC. (DCTH) 8-K Current Report: November 9, 2026

Item 2.02Item EX-99.1DCTH overview

Short answer

DELCATH SYSTEMS, INC. (DCTH) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Delcath announced third-quarter 2026 financial results and business highlights for the quarter ended September 30, 2026.

DELCATH SYSTEMS, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Delcath announced third-quarter 2026 financial results and business highlights for the quarter ended September 30, 2026
  • Exhibit 99.1 contains the substantive results and operating update investors should review

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $35.1M, up from $20.6M, led by HEPZATO revenue of $32.7M
  • Net income $7.0M versus $0.8M, with adjusted EBITDA $11.5M versus $5.3M
  • Gross margin expanded to 89% from 87%, supporting improved operating leverage
  • Cash and investments $104.3M with no debt, providing funding for commercial expansion and clinical development
  • 2026 revenue guidance raised to $115M-$117M, implying HEPZATO volume growth of at least 41% over 2025

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other DELCATH SYSTEMS, INC. 8-K filings

Get the next DCTH 8-K as it lands

Follow DCTH for push alerts, or ask the research agent what this filing means.